Investors
NuPathe is a privately-held company supported by individual and institutional investors. NuPathe’s institutional investors include highly experienced and respected venture capitalists, including Battelle Ventures, Birchmere Ventures, Quaker BioVentures, Safeguard Scientifics (NYSE: SFE), SR One, BioAdvance, and Ben Franklin Technology Partners of Southeastern Pennsylvania.
For more information, please visit:
· Battelle Ventures
www.battelleventures.com
· Birchmere Ventures
· Quaker BioVentures
· Safeguard Scientifics (NYSE: SFE)
· SR One